-       Report 
- February 2024
-  112 Pages 
- Global 
   From       €4249EUR$4,750USD£3,737GBP 
          -       Report 
- April 2023
-  113 Pages 
- Global 
   From       €4249EUR$4,750USD£3,737GBP 
          -       Report 
- April 2023
-  120 Pages 
- Global 
   From       €4249EUR$4,750USD£3,737GBP 
          -       Report 
- April 2023
-  117 Pages 
- Global 
   From       €4249EUR$4,750USD£3,737GBP 
            -       Report 
- May 2024
-  132 Pages 
- Global 
   From       €4941EUR$5,524USD£4,346GBP 
      €5813EUR$6,499USD£5,113GBP 
             -       Report 
- May 2024
-  131 Pages 
- Global 
   From       €4941EUR$5,524USD£4,346GBP 
      €5813EUR$6,499USD£5,113GBP 
            -       Report 
- May 2024
-  129 Pages 
- Global 
   From       €4941EUR$5,524USD£4,346GBP 
      €5813EUR$6,499USD£5,113GBP 
            -       Report 
- May 2024
-  128 Pages 
- Global 
   From       €4941EUR$5,524USD£4,346GBP 
      €5813EUR$6,499USD£5,113GBP 
            -       Report 
- May 2024
-  128 Pages 
- Global 
   From       €4941EUR$5,524USD£4,346GBP 
      €5813EUR$6,499USD£5,113GBP 
            -       Report 
- May 2024
-  133 Pages 
- Global 
   From       €4941EUR$5,524USD£4,346GBP 
      €5813EUR$6,499USD£5,113GBP 
            -       Report 
- May 2024
-  137 Pages 
- Global 
   From       €4941EUR$5,524USD£4,346GBP 
      €5813EUR$6,499USD£5,113GBP 
            -       Report 
- May 2024
-  131 Pages 
- Global 
   From       €4941EUR$5,524USD£4,346GBP 
      €5813EUR$6,499USD£5,113GBP 
            -       Report 
- May 2024
-  135 Pages 
- Global 
   From       €4941EUR$5,524USD£4,346GBP 
      €5813EUR$6,499USD£5,113GBP 
            -       Report 
- May 2024
-  136 Pages 
- Global 
   From       €4941EUR$5,524USD£4,346GBP 
      €5813EUR$6,499USD£5,113GBP 
            -       Report 
- May 2024
-  140 Pages 
- Global 
   From       €4941EUR$5,524USD£4,346GBP 
      €5813EUR$6,499USD£5,113GBP 
          -       Report 
- September 2025
-  70 Pages 
- India 
   From       €3131EUR$3,500USD£2,754GBP 
          -       Report 
- September 2025
-  70 Pages 
- India 
   From       €3131EUR$3,500USD£2,754GBP 
          -       Report 
- September 2025
-  70 Pages 
- India 
   From       €3131EUR$3,500USD£2,754GBP 
          -       Report 
- September 2025
-  70 Pages 
- India 
   From       €3131EUR$3,500USD£2,754GBP 
          -       Report 
- September 2025
-  88 Pages 
- India 
   From       €3131EUR$3,500USD£2,754GBP 
       
       The Urological Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat urological disorders. These disorders include urinary tract infections, bladder control issues, kidney stones, prostate cancer, and erectile dysfunction. Companies in this market develop and market drugs that can help to reduce the symptoms of these disorders, as well as provide treatments for them.
Some of the major players in the Urological Disorders    Drugs market include Pfizer, Merck, AstraZeneca, GlaxoSmithKline, and Sanofi. These companies have a wide range of products that are used to treat urological disorders, including antibiotics, antifungals, and anti-inflammatory drugs. Additionally, they have developed drugs that can help to reduce the symptoms of these disorders, such as pain relievers and muscle relaxants. Show Less   Read more